Status:
TERMINATED
The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD
Lead Sponsor:
Inonu University
Conditions:
COPD Acute Exacerbation
Eligibility:
All Genders
18-80 years
Brief Summary
This study was designed to evaluate the hypothesis that nebulized budesonide) might be an alternative to systemic corticosteroids (SC) in the treatment of patients with acute exacerbations of COPD (AE...
Detailed Description
Patients, hospitalized with AECOPD, were randomized into three groups. Group I received only bronchodilator treatment (BDT), Group II received SC (40 mg prednisolon) plus BDT, and Group III received n...
Eligibility Criteria
Inclusion
- COPD patients who were admitted to our pulmonary department for an acute exacerbation were prospectively enrolled in the study
Exclusion
- COPD patients hospitalized with specific reasons like pneumonia, pulmonary emboli, congestive heart failure, pneumothorax etc. as the cause of acute exacerbation, or patients with risk of imminent respiratory failure requiring mechanical ventilation or direct admission to the ICU were excluded.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
End Date :
October 1 2005
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00274222
Start Date
January 1 2003
End Date
October 1 2005
Last Update
January 10 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.